Latest Regulatory Approvals News

The Supreme Court of New South Wales has approved MaxoTel's acquisition of all remaining Vonex shares, triggering a suspension of Vonex trading and impending delisting from the ASX.

Moab Minerals is set to acquire full ownership of Imbas Mining, unlocking rights to earn up to 80% of the Sasare Gold and Copper Project in Zambia, a site with notable historic gold production and promising copper targets. The acquisition paves the way for an initial exploration campaign targeting both gold and copper mineralisation.

EVE Health Group has raised $1.1 million to accelerate the commercial rollout of its innovative pharmaceutical products Dyspro and Libbo, signaling strong investor confidence in its growth strategy.

Elders Limited has secured regulatory approval to acquire Delta Agribusiness, subject to divesting six Western Australian branches, while maintaining a positive outlook for FY25 earnings.

The ACCC has approved Elders Limited’s acquisition of Delta Agribusiness, contingent on Elders divesting six Delta retail stores in Western Australia to preserve local competition.

Aurumin Limited has secured Supreme Court approval to convene shareholder and optionholder meetings for Brightstar Resources’ proposed full acquisition. The company’s directors unanimously back the schemes, setting the stage for a pivotal vote in November.

NH3 Clean Energy updates investors on the WAH2 clean ammonia project, highlighting strong market potential, strategic partnerships, and robust project economics as it moves toward a Final Investment Decision.

PainChek Limited has achieved a landmark FDA De Novo classification for its PainChek Adult App, positioning it as the first regulated medical device for pain assessment in the US aged care sector and opening a $100 million annual market opportunity.

Power Minerals Limited has secured an option to acquire the Gamma Heavy Rare Earths Project in California, adjacent to the Mountain Pass Mine, backed by a $4.1 million placement to accelerate exploration.

Neurotech International has secured a key FDA designation for its lead drug NTI164, advancing its potential to treat Rett syndrome with regulatory and financial benefits.

Adamantem Capital Management has completed its due diligence on Apiam Animal Health and extended its exclusivity period to negotiate a potential $0.87 per share acquisition. The deal remains subject to approvals and binding agreements.

Eastern Metals Limited has entered a definitive agreement to acquire Raptor Resources Limited, adding significant copper and gold assets in Canada and Western Australia, alongside a planned capital raise to fund exploration and ASX reinstatement.